Vietnam Veterans Liver Fluke Cancer Study Act

HR 4424, the Vietnam Veterans Liver Fluke Cancer Study Act, directs the Department of Veterans Affairs to study the rate of cholangiocarcinoma (a type of bile duct cancer) among veterans who served in the Vietnam theater during the Vietnam era. The bill requires the VA, working with the CDC, to analyze existing cancer registry data to compare cancer rates between these veterans and the general U.S. population, breaking down results by age, gender, race, ethnicity, and location. The VA must report its findings and recommendations to Congress within one year of completing the study, with ongoing periodic updates. This study aims to identify patterns and inform potential future actions for affected veterans, without changing current benefits or eligibility.